Emerging Biomarker Research in PD
Extracellular vesicles (EVs) in effluent may help monitor peritoneal membrane health, inflammation, and fibrosis. The vesicles contain molecular signals that could provide early earning of membrane damage or early failure.
Read the full article » | Posted 03-12-2026
Related Articles
- Proof of Concept for Silicon Nanopore Membrane Implantable HD Posted 10-05-2026
- AWAK PD To Go Posted 10-05-2026
- The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
- Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026

